These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25744879)

  • 1. Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
    Kotagale NR; Chopde CT; Umekar MJ; Taksande BG
    Eur J Pharmacol; 2015 May; 754():190-8. PubMed ID: 25744879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice.
    Bagosi Z; Palotai M; Simon B; Bokor P; Buzás A; Balangó B; Pintér D; Jászberényi M; Csabafi K; Szabó G
    Brain Res; 2016 Dec; 1652():21-29. PubMed ID: 27693397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agmatine inhibits nicotine withdrawal induced cognitive deficits in inhibitory avoidance task in rats: Contribution of α
    Kotagale NR; Ali MT; Chopde CT; Umekar MJ; Taksande BG
    Pharmacol Biochem Behav; 2018 Apr; 167():42-49. PubMed ID: 29530492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
    Taksande BG; Kotagale NR; Patel MR; Shelkar GP; Ugale RR; Chopde CT
    Eur J Pharmacol; 2010 Jul; 637(1-3):89-101. PubMed ID: 20394743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice.
    Patel D; Vishwakarma PK; Patel R; Jain NS
    Behav Brain Res; 2021 Feb; 399():112997. PubMed ID: 33166570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
    Ohmura Y; Jutkiewicz EM; Domino EF
    Pharmacol Biochem Behav; 2011 Jun; 98(4):552-8. PubMed ID: 21354201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway.
    Gawali NB; Bulani VD; Gursahani MS; Deshpande PS; Kothavade PS; Juvekar AR
    Brain Res; 2017 May; 1663():66-77. PubMed ID: 28302445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
    Mattioli L; Perfumi M
    J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat.
    Motaghinejad M; Fatima S; Karimian M; Ganji S
    J Basic Clin Physiol Pharmacol; 2016 Jan; 27(1):19-27. PubMed ID: 26512426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
    Damaj MI; Kao W; Martin BR
    J Pharmacol Exp Ther; 2003 Nov; 307(2):526-34. PubMed ID: 12970387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory influence of agmatine in ethanol withdrawal-induced depression in rats: Behavioral and neurochemical evidence.
    Chimthanawala N; Patil S; Agrawal R; Kotagale NR; Umekar MJ; Taksande BG
    Alcohol; 2020 Mar; 83():67-74. PubMed ID: 31520686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice.
    Thakre PP; Tundulwar MR; Chopde CT; Ugale RR
    Neurosci Lett; 2013 Apr; 541():144-9. PubMed ID: 23485740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice.
    Taksande BG; Faldu DS; Dixit MP; Sakaria JN; Aglawe MM; Umekar MJ; Kotagale NR
    Eur J Pharmacol; 2013 Nov; 720(1-3):115-20. PubMed ID: 24183973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice.
    Khurana K; Kumar M; Bansal N
    Neurotox Res; 2021 Dec; 39(6):1920-1936. PubMed ID: 34613588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
    Varani AP; Moutinho LM; Calvo M; Balerio GN
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Wing VC; Shoaib M
    Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agmatine prevents the manifestation of impulsive burying and depression-like behaviour in progesterone withdrawn female rats.
    Vinchurney MD; Dhokne MD; Kotagale N; Umekar MJ; Taksande B
    Horm Behav; 2023 Jun; 152():105361. PubMed ID: 37163843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is agmatine an endogenous anxiolytic/antidepressant agent?
    Aricioglu F; Altunbas H
    Ann N Y Acad Sci; 2003 Dec; 1009():136-40. PubMed ID: 15028578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
    Chae Y; Yeom M; Han JH; Park HJ; Hahm DH; Shim I; Lee HS; Lee H
    Neurosci Lett; 2008 Jan; 430(2):98-102. PubMed ID: 18060697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.